1
|
Masurier N, Moreau E, Lartigue C, Gaumet V, Chezal JM, Heitz A, Teulade JC, Chavignon O. New Opportunities with the Duff Reaction. J Org Chem 2008; 73:5989-92. [DOI: 10.1021/jo800700b] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Nicolas Masurier
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Emmanuel Moreau
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Claire Lartigue
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Vincent Gaumet
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Jean-Michel Chezal
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Annie Heitz
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Jean-Claude Teulade
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| | - Olivier Chavignon
- E.A.4231, Faculté de Pharmacie, 28 place Henri Dunant, B.P. 38, 63001 Clermont-Ferrand Cedex 1, France, and CBS, CNRS, INSERM, 29, rue de Navacelles, 34060 Montpellier, France
| |
Collapse
|
3
|
Abstract
The identification and characterization of adenosine receptors and the development of potent, receptor subtype-selective agonists and antagonists has been an active area of research for the past 20 years. Major recent advances in the field have been the cloning of several adenosine receptor subtypes of different species, including the discovery of a new subtype, designated A3, the discovery and development of new agonists and antagonists, particularly those with selectivity for the A2a adenosine receptor, the characterization of signal transduction pathways, and the development of agents which act indirectly on the adenosine receptor system. The present article focusses on aspects of pharmaceutical/medicinal chemistry related to adenosine receptors.
Collapse
Affiliation(s)
- C E Müller
- Pharmazeutisches Institut, Pharmazeutische Chemie, Tübingen, Germany
| | | |
Collapse
|